Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses

<p>Abstract</p> <p>Background</p> <p>Human T-cell leukemia virus type 1 (HTLV-1) and type 2 both target T lymphocytes, yet induce radically different phenotypic outcomes. HTLV-1 is a causative agent of Adult T-cell leukemia (ATL), whereas HTLV-2, highly similar to HTLV-...

Full description

Bibliographic Details
Main Authors: Simonis Nicolas, Rual Jean-François, Lemmens Irma, Boxus Mathieu, Hirozane-Kishikawa Tomoko, Gatot Jean-Stéphane, Dricot Amélie, Hao Tong, Vertommen Didier, Legros Sébastien, Daakour Sarah, Klitgord Niels, Martin Maud, Willaert Jean-François, Dequiedt Franck, Navratil Vincent, Cusick Michael E, Burny Arsène, Van Lint Carine, Hill David E, Tavernier Jan, Kettmann Richard, Vidal Marc, Twizere Jean-Claude
Format: Article
Language:English
Published: BMC 2012-03-01
Series:Retrovirology
Subjects:
Online Access:http://www.retrovirology.com/content/9/1/26
_version_ 1818066346703847424
author Simonis Nicolas
Rual Jean-François
Lemmens Irma
Boxus Mathieu
Hirozane-Kishikawa Tomoko
Gatot Jean-Stéphane
Dricot Amélie
Hao Tong
Vertommen Didier
Legros Sébastien
Daakour Sarah
Klitgord Niels
Martin Maud
Willaert Jean-François
Dequiedt Franck
Navratil Vincent
Cusick Michael E
Burny Arsène
Van Lint Carine
Hill David E
Tavernier Jan
Kettmann Richard
Vidal Marc
Twizere Jean-Claude
author_facet Simonis Nicolas
Rual Jean-François
Lemmens Irma
Boxus Mathieu
Hirozane-Kishikawa Tomoko
Gatot Jean-Stéphane
Dricot Amélie
Hao Tong
Vertommen Didier
Legros Sébastien
Daakour Sarah
Klitgord Niels
Martin Maud
Willaert Jean-François
Dequiedt Franck
Navratil Vincent
Cusick Michael E
Burny Arsène
Van Lint Carine
Hill David E
Tavernier Jan
Kettmann Richard
Vidal Marc
Twizere Jean-Claude
author_sort Simonis Nicolas
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Human T-cell leukemia virus type 1 (HTLV-1) and type 2 both target T lymphocytes, yet induce radically different phenotypic outcomes. HTLV-1 is a causative agent of Adult T-cell leukemia (ATL), whereas HTLV-2, highly similar to HTLV-1, causes no known overt disease. HTLV gene products are engaged in a dynamic struggle of activating and antagonistic interactions with host cells. Investigations focused on one or a few genes have identified several human factors interacting with HTLV viral proteins. Most of the available interaction data concern the highly investigated HTLV-1 Tax protein. Identifying shared and distinct host-pathogen protein interaction profiles for these two viruses would enlighten how they exploit distinctive or common strategies to subvert cellular pathways toward disease progression.</p> <p>Results</p> <p>We employ a scalable methodology for the systematic mapping and comparison of pathogen-host protein interactions that includes stringent yeast two-hybrid screening and systematic retest, as well as two independent validations through an additional protein interaction detection method and a functional transactivation assay. The final data set contained 166 interactions between 10 viral proteins and 122 human proteins. Among the 166 interactions identified, 87 and 79 involved HTLV-1 and HTLV-2 -encoded proteins, respectively. Targets for HTLV-1 and HTLV-2 proteins implicate a diverse set of cellular processes including the ubiquitin-proteasome system, the apoptosis, different cancer pathways and the Notch signaling pathway.</p> <p>Conclusions</p> <p>This study constitutes a first pass, with homogeneous data, at comparative analysis of host targets for HTLV-1 and -2 retroviruses, complements currently existing data for formulation of systems biology models of retroviral induced diseases and presents new insights on biological pathways involved in retroviral infection.</p>
first_indexed 2024-12-10T15:06:20Z
format Article
id doaj.art-2531aa0f51634cccb86e6e3a3db3decb
institution Directory Open Access Journal
issn 1742-4690
language English
last_indexed 2024-12-10T15:06:20Z
publishDate 2012-03-01
publisher BMC
record_format Article
series Retrovirology
spelling doaj.art-2531aa0f51634cccb86e6e3a3db3decb2022-12-22T01:44:02ZengBMCRetrovirology1742-46902012-03-01912610.1186/1742-4690-9-26Host-pathogen interactome mapping for HTLV-1 and -2 retrovirusesSimonis NicolasRual Jean-FrançoisLemmens IrmaBoxus MathieuHirozane-Kishikawa TomokoGatot Jean-StéphaneDricot AmélieHao TongVertommen DidierLegros SébastienDaakour SarahKlitgord NielsMartin MaudWillaert Jean-FrançoisDequiedt FranckNavratil VincentCusick Michael EBurny ArsèneVan Lint CarineHill David ETavernier JanKettmann RichardVidal MarcTwizere Jean-Claude<p>Abstract</p> <p>Background</p> <p>Human T-cell leukemia virus type 1 (HTLV-1) and type 2 both target T lymphocytes, yet induce radically different phenotypic outcomes. HTLV-1 is a causative agent of Adult T-cell leukemia (ATL), whereas HTLV-2, highly similar to HTLV-1, causes no known overt disease. HTLV gene products are engaged in a dynamic struggle of activating and antagonistic interactions with host cells. Investigations focused on one or a few genes have identified several human factors interacting with HTLV viral proteins. Most of the available interaction data concern the highly investigated HTLV-1 Tax protein. Identifying shared and distinct host-pathogen protein interaction profiles for these two viruses would enlighten how they exploit distinctive or common strategies to subvert cellular pathways toward disease progression.</p> <p>Results</p> <p>We employ a scalable methodology for the systematic mapping and comparison of pathogen-host protein interactions that includes stringent yeast two-hybrid screening and systematic retest, as well as two independent validations through an additional protein interaction detection method and a functional transactivation assay. The final data set contained 166 interactions between 10 viral proteins and 122 human proteins. Among the 166 interactions identified, 87 and 79 involved HTLV-1 and HTLV-2 -encoded proteins, respectively. Targets for HTLV-1 and HTLV-2 proteins implicate a diverse set of cellular processes including the ubiquitin-proteasome system, the apoptosis, different cancer pathways and the Notch signaling pathway.</p> <p>Conclusions</p> <p>This study constitutes a first pass, with homogeneous data, at comparative analysis of host targets for HTLV-1 and -2 retroviruses, complements currently existing data for formulation of systems biology models of retroviral induced diseases and presents new insights on biological pathways involved in retroviral infection.</p>http://www.retrovirology.com/content/9/1/26HTLVInteractomeRetrovirusORFeomeTaxHBZ
spellingShingle Simonis Nicolas
Rual Jean-François
Lemmens Irma
Boxus Mathieu
Hirozane-Kishikawa Tomoko
Gatot Jean-Stéphane
Dricot Amélie
Hao Tong
Vertommen Didier
Legros Sébastien
Daakour Sarah
Klitgord Niels
Martin Maud
Willaert Jean-François
Dequiedt Franck
Navratil Vincent
Cusick Michael E
Burny Arsène
Van Lint Carine
Hill David E
Tavernier Jan
Kettmann Richard
Vidal Marc
Twizere Jean-Claude
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
Retrovirology
HTLV
Interactome
Retrovirus
ORFeome
Tax
HBZ
title Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
title_full Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
title_fullStr Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
title_full_unstemmed Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
title_short Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
title_sort host pathogen interactome mapping for htlv 1 and 2 retroviruses
topic HTLV
Interactome
Retrovirus
ORFeome
Tax
HBZ
url http://www.retrovirology.com/content/9/1/26
work_keys_str_mv AT simonisnicolas hostpathogeninteractomemappingforhtlv1and2retroviruses
AT rualjeanfrancois hostpathogeninteractomemappingforhtlv1and2retroviruses
AT lemmensirma hostpathogeninteractomemappingforhtlv1and2retroviruses
AT boxusmathieu hostpathogeninteractomemappingforhtlv1and2retroviruses
AT hirozanekishikawatomoko hostpathogeninteractomemappingforhtlv1and2retroviruses
AT gatotjeanstephane hostpathogeninteractomemappingforhtlv1and2retroviruses
AT dricotamelie hostpathogeninteractomemappingforhtlv1and2retroviruses
AT haotong hostpathogeninteractomemappingforhtlv1and2retroviruses
AT vertommendidier hostpathogeninteractomemappingforhtlv1and2retroviruses
AT legrossebastien hostpathogeninteractomemappingforhtlv1and2retroviruses
AT daakoursarah hostpathogeninteractomemappingforhtlv1and2retroviruses
AT klitgordniels hostpathogeninteractomemappingforhtlv1and2retroviruses
AT martinmaud hostpathogeninteractomemappingforhtlv1and2retroviruses
AT willaertjeanfrancois hostpathogeninteractomemappingforhtlv1and2retroviruses
AT dequiedtfranck hostpathogeninteractomemappingforhtlv1and2retroviruses
AT navratilvincent hostpathogeninteractomemappingforhtlv1and2retroviruses
AT cusickmichaele hostpathogeninteractomemappingforhtlv1and2retroviruses
AT burnyarsene hostpathogeninteractomemappingforhtlv1and2retroviruses
AT vanlintcarine hostpathogeninteractomemappingforhtlv1and2retroviruses
AT hilldavide hostpathogeninteractomemappingforhtlv1and2retroviruses
AT tavernierjan hostpathogeninteractomemappingforhtlv1and2retroviruses
AT kettmannrichard hostpathogeninteractomemappingforhtlv1and2retroviruses
AT vidalmarc hostpathogeninteractomemappingforhtlv1and2retroviruses
AT twizerejeanclaude hostpathogeninteractomemappingforhtlv1and2retroviruses